Perbak Capital Partners LLP purchased a new stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,943 shares of the semiconductor company's stock, valued at approximately $214,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in LRCX. Brighton Jones LLC increased its stake in Lam Research by 1,032.4% during the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company's stock valued at $1,025,000 after acquiring an additional 12,936 shares during the period. Ancora Advisors LLC lifted its stake in shares of Lam Research by 1,396.0% in the 4th quarter. Ancora Advisors LLC now owns 4,159 shares of the semiconductor company's stock valued at $300,000 after purchasing an additional 3,881 shares during the period. Algert Global LLC increased its position in shares of Lam Research by 373.9% in the 4th quarter. Algert Global LLC now owns 3,289 shares of the semiconductor company's stock valued at $238,000 after buying an additional 2,595 shares in the last quarter. Bamco Inc. NY increased its holdings in Lam Research by 985.3% during the 4th quarter. Bamco Inc. NY now owns 9,019 shares of the semiconductor company's stock worth $651,000 after purchasing an additional 8,188 shares in the last quarter. Finally, Baird Financial Group Inc. increased its holdings in Lam Research by 961.2% during the 4th quarter. Baird Financial Group Inc. now owns 543,080 shares of the semiconductor company's stock worth $39,227,000 after purchasing an additional 491,903 shares in the last quarter. 84.61% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several brokerages have recently weighed in on LRCX. Erste Group Bank began coverage on Lam Research in a report on Thursday, August 14th. They issued a "buy" rating for the company. Wall Street Zen upgraded Lam Research from a "hold" rating to a "buy" rating in a report on Saturday, August 2nd. Oppenheimer raised their price objective on Lam Research from $110.00 to $120.00 and gave the company an "outperform" rating in a report on Thursday, July 31st. B. Riley restated a "buy" rating and set a $115.00 price objective (up previously from $95.00) on shares of Lam Research in a report on Wednesday, June 18th. Finally, Citigroup boosted their price objective on Lam Research from $108.00 to $113.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Twenty investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $107.22.
Get Our Latest Stock Report on Lam Research
Lam Research Price Performance
LRCX traded up $2.53 during trading on Friday, hitting $102.95. 8,138,513 shares of the stock traded hands, compared to its average volume of 10,784,377. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $108.02. The company has a market cap of $130.30 billion, a price-to-earnings ratio of 24.75, a PEG ratio of 1.32 and a beta of 1.76. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55. The business has a 50 day moving average price of $99.87 and a 200 day moving average price of $85.82.
Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.12. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The company had revenue of $5.17 billion during the quarter, compared to the consensus estimate of $4.99 billion. During the same period in the prior year, the business earned $1.03 earnings per share. The company's revenue for the quarter was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Equities research analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.
Lam Research Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th will be given a $0.26 dividend. This is a boost from Lam Research's previous quarterly dividend of $0.23. The ex-dividend date is Wednesday, September 24th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 1.0%. Lam Research's dividend payout ratio is presently 22.12%.
Lam Research Company Profile
(
Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Stories

Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.